{"id":4087,"date":"2025-09-26T09:07:17","date_gmt":"2025-09-26T02:07:17","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=4087"},"modified":"2025-09-29T17:16:07","modified_gmt":"2025-09-29T10:16:07","slug":"benzylpenicillin-for-injection","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/benzylpenicillin-for-injection\/","title":{"rendered":"Benzylpenicillin for Injection"},"content":{"rendered":"

BP 2025 (Ph. Eur. 11.6 update)<\/p>\n

Action and use<\/strong><\/p>\n

Penicillin antibacterial.<\/p>\n

DEFINITION<\/h2>\n
Benzylpenicillin for Injection is a sterile material consisting of Benzylpenicillin Potassium or Benzylpenicillin Sodium with or without excipients. It is supplied in a sealed container.<\/p>\n
The contents of the sealed container comply with the requirements for Powders for Injections or Infusions stated under Parenteral Preparations and with the following requirements.<\/p>\n
Content of penicillins, calculated as C_{16<\/sub>H_{18<\/sub>N_{2<\/sub>O_{4<\/sub>S <\/strong><\/p>\n}}}}
95.0 to 105.0% of the content of benzylpenicillin stated on the label.<\/p>\n
IDENTIFICATION<\/p>\n
A. The infrared absorption spectrum, Appendix II A, is concordant with the spectrum of benzylpenicillin potassium EPCRS or benzylpenicillin sodium EPCRS as appropriate.<\/p>\n
B. In the Assay, the retention time of the principal peak in the chromatogram obtained with solution (1) is similar to that of the principal peak in the chromatogram obtained with solution (2).<\/p>\n
TESTS<\/h2>\n
Acidity or alkalinity<\/strong><\/p>\n
pH of a solution containing the equivalent of 10.0% w\/v of benzylpenicillin, 5.5 to 7.5, Appendix V L.<\/p>\n
Related substances<\/strong><\/p>\n
Carry out the method for liquid chromatography, Appendix III D, using the following solutions in water, prepared immediately before use.<\/p>\n
(1) Dissolve a quantity of the contents of a sealed container to produce a solution containing the equivalent of 0.4% w\/v of benzylpenicillin.<\/p>\n
(2) Dilute 1 volume of solution (1) to 100 volumes.<\/p>\n
(3) Dissolve 5 mg of benzylpenicillin for system suitability EPCRS in 0.35 mL of methanol R1 and add 0.65 mL of water.<\/p>\n
(4) Dilute 1 volume of solution (2) to 5 volumes.<\/p>\n
CHROMATOGRAPHIC CONDITIONS<\/h3>\n
(a) Use a stainless steel column (15 cm \u00d7 4.6 mm) packed with end-capped octadecylsilyl silica gel for chromatography (3 \u03bcm) (YMC-Pack Pro is suitable).<\/p>\n
(b) Use gradient elution and the mobile phase described below.<\/p>\n
(c) Use a flow rate of 1.5 mL per minute.<\/p>\n
(d) Use a column temperature of 50\u00b0.<\/p>\n
(e) Use a detection wavelength of 225 nm.<\/p>\n
(f) Inject 20 \u03bcL of each solution.<\/p>\n
MOBILE PHASE<\/h3>\n
Mobile phase A 10 volumes of a 6.8% w\/v solution of potassium dihydrogen orthophosphate adjusted to pH 3.4 with a 50% w\/v solution of orthophosphoric acid, 30 volumes of methanol R1 and 60 volumes of water.
\nMobile phase B 10 volumes of a 6.8% w\/v solution of potassium dihydrogen orthophosphate adjusted to pH 3.4 with a 50% w\/v solution of orthophosphoric acid, 35 volumes of water and 55 volumes of methanol R1.<\/p>\n\n\n\n\n\n\n
Time (min)<\/td>\n Mobile Phase A (% V\/V)<\/td>\n Mobile Phase B (% V\/V)<\/td>\n Comment<\/td>\n<\/tr>\n
0 – 7<\/td>\n 70<\/td>\n 30<\/td>\n isocratic<\/td>\n<\/tr>\n
7 – 17<\/td>\n 70 \u2192 0<\/td>\n 30 \u2192 100<\/td>\n linear gradient<\/td>\n<\/tr>\n
17 – 22<\/td>\n 0<\/td>\n 100<\/td>\n isocratic<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
<\/p>\n
When the chromatograms are recorded under the prescribed conditions, the relative retentions with reference to benzylpenicillin (retention time about 7 minutes) are: impurity A, about 0.2; impurity D, about 0.3; impurity C, about 0.4; impurity E, about 0.48 and 0.55; impurity B, about 0.6; impurity F, about 0.81 and 0.83; impurity G, about 1.5 and impurity H, about 1.9.<\/p>\n
SYSTEM SUITABILITY<\/h3>\n
The test is not valid unless, in the chromatogram obtained with solution (3), the resolution between the peaks due to the epimers of impurity F is at least 1.2; and the resolution between the peaks due to impurities D and C is at least 1.5.<\/p>\n
LIMITS<\/h3>\n
In the chromatogram obtained with solution (1):<\/p>\n
identify any peaks corresponding to impurities A to H using the chromatogram supplied with benzylpenicillin for system suitability EPCRS and the chromatogram obtained with solution (3). Multiply the area of any peaks corresponding to impurity A, impurity D, impurity E and impurity F by the following correction factors respectively: 1.3, 0.6, 2.0 and 1.7.<\/p>\n
the sum of the areas of any peaks corresponding to the isomers of impurity E is not greater than twice the area of the principal peak in the chromatogram obtained with solution (2) (2.0%);<\/p>\n
the sum of the areas of any peaks corresponding to the epimers of impurity F is not greater than twice the area of the principal peak in the chromatogram obtained with solution (2) (2.0%);<\/p>\n
the area of any peak corresponding to impurity B is not greater than half the area of the principal peak in the chromatogram obtained with solution (2) (0.5%);<\/p>\n
the area of any other secondary peak is not greater than the area of the principal peak in the chromatogram obtained with solution (4) (0.2%);<\/p>\n
the sum of the areas of all secondary peaks is not greater than 3 times the area of the principal peak in the chromatogram obtained with solution (2) (3.0%).<\/p>\n
Disregard any peak with an area less than 0.75 times the area of the principal peak in the chromatogram obtained with
\nsolution (4) (0.15%).<\/p>\n
Loss on drying<\/strong><\/p>\n
When dried to constant weight at 105\u00b0, lose not more than 1.0% of their weight. Use 1 g.<\/p>\n
Bacterial endotoxins<\/strong><\/p>\n
Carry out the test for bacterial endotoxins, Appendix XIV C. Dissolve the contents of the sealed container in water BET to give a solution containing the equivalent of 10 mg of benzylpenicillin per mL (solution A). The endotoxin limit of solution A is 1.6 IU per mL.<\/p>\n
ASSAY<\/h2>\n
Determine the weight of the contents of 10 containers as described in the test for uniformity of weight, Appendix XII C1, Powders for Parenteral Administration.<\/p>\n
Carry out the method for liquid chromatography, Appendix III D, using the following solutions in water prepared immediately before use.<\/p>\n
(1) Dissolve a quantity of the mixed contents of the 10 containers to produce a solution containing the equivalent of 0.1% w\/v of benzylpenicillin.<\/p>\n
(2) 0.11% w\/v of benzylpenicillin sodium EPCRS.<\/p>\n
CHROMATOGRAPHIC CONDITIONS<\/h3>\n
(a) Use a stainless steel column (15 cm \u00d7 4.6 mm) packed with end-capped octadecylsilyl silica gel for chromatography (3 \u03bcm) (YMC-Pack Pro is suitable).<\/p>\n
(b) Use isocratic elution and the mobile phase described below.<\/p>\n
(c) Use a flow rate of 1.2 mL per minute.<\/p>\n
(d) Use a column temperature of 50\u00b0.<\/p>\n
(e) Use a detection wavelength of 225 nm.<\/p>\n
(f) Inject 10 \u03bcL of each solution.<\/p>\n
MOBILE PHASE<\/h3>\n
Mix 10 volumes of a 6.8% w\/v solution of potassium dihydrogen orthophosphate, adjusted to pH 3.5 with a 50% w\/v solution of dilute orthophosphoric acid, 36 volumes of methanol and 54 volumes of water.<\/p>\n
DETERMINATION OF CONTENT<\/h3>\n
Calculate the content of penicillins, as C_{16<\/sub>H_{18<\/sub>N_{2<\/sub>O_{4<\/sub>S, in a container of average content weight using the declared content of C_{16<\/sub>H_{17<\/sub>N_{2<\/sub>NaO_{4<\/sub>S in benzylpenicillin sodium EPCRS. Each mg of C_{16<\/sub>H_{17<\/sub>N_{2<\/sub>NaO_{4<\/sub>S is equivalent to 0.9383 mg of C_{16<\/sub>H_{18<\/sub>N_{2<\/sub>O_{4<\/sub>S.<\/p>\n}}}}}}}}}}}}}}}}
STORAGE<\/h2>\n
The sealed container should be stored at a temperature not exceeding 30\u00b0.<\/p>\n
LABELLING<\/h2>\n
The label of the sealed container states (1) whether the contents are Benzylpenicillin Potassium or Benzylpenicillin Sodium; (2) the quantity of Benzylpenicillin Potassium or Benzylpenicillin Sodium contained in it in terms of the equivalent amount of benzylpenicillin.<\/p>\n
IMPURITIES<\/h2>\n
The impurities limites by the requirements of this monograph include those listed under Benzylpenicillin Potassium and Benzylpenicillin Sodium.<\/p>\n","protected":false},"excerpt":{"rendered":"
BP 2025 (Ph. Eur. 11.6 update) Action and use Penicillin antibacterial. DEFINITION Benzylpenicillin for Injection is a sterile material consisting of Benzylpenicillin Potassium or Benzylpenicillin Sodium with or without excipients. It is supplied in a sealed container. The contents of the sealed container comply with the requirements for Powders for Injections or Infusions stated under…<\/p>\n","protected":false},"author":5,"featured_media":4127,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[175],"tags":[],"class_list":["post-4087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-formulated-preparations-specific-monographs"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/4087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=4087"}],"version-history":[{"count":3,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/4087\/revisions"}],"predecessor-version":[{"id":5904,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/4087\/revisions\/5904"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/4127"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=4087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=4087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=4087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

Time (min)<\/td>\n	Mobile Phase A (% V\/V)<\/td>\n	Mobile Phase B (% V\/V)<\/td>\n	Comment<\/td>\n<\/tr>\n
0 – 7<\/td>\n	70<\/td>\n	30<\/td>\n	isocratic<\/td>\n<\/tr>\n
7 – 17<\/td>\n	70 \u2192 0<\/td>\n	30 \u2192 100<\/td>\n	linear gradient<\/td>\n<\/tr>\n
17 – 22<\/td>\n	0<\/td>\n	100<\/td>\n	isocratic<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n <\/p>\n When the chromatograms are recorded under the prescribed conditions, the relative retentions with reference to benzylpenicillin (retention time about 7 minutes) are: impurity A, about 0.2; impurity D, about 0.3; impurity C, about 0.4; impurity E, about 0.48 and 0.55; impurity B, about 0.6; impurity F, about 0.81 and 0.83; impurity G, about 1.5 and impurity H, about 1.9.<\/p>\n SYSTEM SUITABILITY<\/h3>\n The test is not valid unless, in the chromatogram obtained with solution (3), the resolution between the peaks due to the epimers of impurity F is at least 1.2; and the resolution between the peaks due to impurities D and C is at least 1.5.<\/p>\n LIMITS<\/h3>\n In the chromatogram obtained with solution (1):<\/p>\n identify any peaks corresponding to impurities A to H using the chromatogram supplied with benzylpenicillin for system suitability EPCRS and the chromatogram obtained with solution (3). Multiply the area of any peaks corresponding to impurity A, impurity D, impurity E and impurity F by the following correction factors respectively: 1.3, 0.6, 2.0 and 1.7.<\/p>\n the sum of the areas of any peaks corresponding to the isomers of impurity E is not greater than twice the area of the principal peak in the chromatogram obtained with solution (2) (2.0%);<\/p>\n the sum of the areas of any peaks corresponding to the epimers of impurity F is not greater than twice the area of the principal peak in the chromatogram obtained with solution (2) (2.0%);<\/p>\n the area of any peak corresponding to impurity B is not greater than half the area of the principal peak in the chromatogram obtained with solution (2) (0.5%);<\/p>\n the area of any other secondary peak is not greater than the area of the principal peak in the chromatogram obtained with solution (4) (0.2%);<\/p>\n the sum of the areas of all secondary peaks is not greater than 3 times the area of the principal peak in the chromatogram obtained with solution (2) (3.0%).<\/p>\n Disregard any peak with an area less than 0.75 times the area of the principal peak in the chromatogram obtained with \nsolution (4) (0.15%).<\/p>\n Loss on drying<\/strong><\/p>\n When dried to constant weight at 105\u00b0, lose not more than 1.0% of their weight. Use 1 g.<\/p>\n Bacterial endotoxins<\/strong><\/p>\n Carry out the test for bacterial endotoxins, Appendix XIV C. Dissolve the contents of the sealed container in water BET to give a solution containing the equivalent of 10 mg of benzylpenicillin per mL (solution A). The endotoxin limit of solution A is 1.6 IU per mL.<\/p>\n ASSAY<\/h2>\n Determine the weight of the contents of 10 containers as described in the test for uniformity of weight, Appendix XII C1, Powders for Parenteral Administration.<\/p>\n Carry out the method for liquid chromatography, Appendix III D, using the following solutions in water prepared immediately before use.<\/p>\n (1) Dissolve a quantity of the mixed contents of the 10 containers to produce a solution containing the equivalent of 0.1% w\/v of benzylpenicillin.<\/p>\n (2) 0.11% w\/v of benzylpenicillin sodium EPCRS.<\/p>\n CHROMATOGRAPHIC CONDITIONS<\/h3>\n (a) Use a stainless steel column (15 cm \u00d7 4.6 mm) packed with end-capped octadecylsilyl silica gel for chromatography (3 \u03bcm) (YMC-Pack Pro is suitable).<\/p>\n (b) Use isocratic elution and the mobile phase described below.<\/p>\n (c) Use a flow rate of 1.2 mL per minute.<\/p>\n (d) Use a column temperature of 50\u00b0.<\/p>\n (e) Use a detection wavelength of 225 nm.<\/p>\n (f) Inject 10 \u03bcL of each solution.<\/p>\n MOBILE PHASE<\/h3>\n Mix 10 volumes of a 6.8% w\/v solution of potassium dihydrogen orthophosphate, adjusted to pH 3.5 with a 50% w\/v solution of dilute orthophosphoric acid, 36 volumes of methanol and 54 volumes of water.<\/p>\n DETERMINATION OF CONTENT<\/h3>\n Calculate the content of penicillins, as C_{16<\/sub>H_{18<\/sub>N_{2<\/sub>O_{4<\/sub>S, in a container of average content weight using the declared content of C_{16<\/sub>H_{17<\/sub>N_{2<\/sub>NaO_{4<\/sub>S in benzylpenicillin sodium EPCRS. Each mg of C_{16<\/sub>H_{17<\/sub>N_{2<\/sub>NaO_{4<\/sub>S is equivalent to 0.9383 mg of C_{16<\/sub>H_{18<\/sub>N_{2<\/sub>O_{4<\/sub>S.<\/p>\n}}}}}}}}}}}}}}}} STORAGE<\/h2>\n The sealed container should be stored at a temperature not exceeding 30\u00b0.<\/p>\n LABELLING<\/h2>\n The label of the sealed container states (1) whether the contents are Benzylpenicillin Potassium or Benzylpenicillin Sodium; (2) the quantity of Benzylpenicillin Potassium or Benzylpenicillin Sodium contained in it in terms of the equivalent amount of benzylpenicillin.<\/p>\n IMPURITIES<\/h2>\n The impurities limites by the requirements of this monograph include those listed under Benzylpenicillin Potassium and Benzylpenicillin Sodium.<\/p>\n","protected":false},"excerpt":{"rendered":" BP 2025 (Ph. Eur. 11.6 update) Action and use Penicillin antibacterial. DEFINITION Benzylpenicillin for Injection is a sterile material consisting of Benzylpenicillin Potassium or Benzylpenicillin Sodium with or without excipients. It is supplied in a sealed container. The contents of the sealed container comply with the requirements for Powders for Injections or Infusions stated under…<\/p>\n","protected":false},"author":5,"featured_media":4127,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[175],"tags":[],"class_list":["post-4087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-formulated-preparations-specific-monographs"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/4087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=4087"}],"version-history":[{"count":3,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/4087\/revisions"}],"predecessor-version":[{"id":5904,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/4087\/revisions\/5904"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/4127"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=4087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=4087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=4087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

SYSTEM SUITABILITY<\/h3>\nThe test is not valid unless, in the chromatogram obtained with solution (3), the resolution between the peaks due to the epimers of impurity F is at least 1.2; and the resolution between the peaks due to impurities D and C is at least 1.5.<\/p>\n

MOBILE PHASE<\/h3>\nMix 10 volumes of a 6.8% w\/v solution of potassium dihydrogen orthophosphate, adjusted to pH 3.5 with a 50% w\/v solution of dilute orthophosphoric acid, 36 volumes of methanol and 54 volumes of water.<\/p>\n

STORAGE<\/h2>\nThe sealed container should be stored at a temperature not exceeding 30\u00b0.<\/p>\n

LABELLING<\/h2>\nThe label of the sealed container states (1) whether the contents are Benzylpenicillin Potassium or Benzylpenicillin Sodium; (2) the quantity of Benzylpenicillin Potassium or Benzylpenicillin Sodium contained in it in terms of the equivalent amount of benzylpenicillin.<\/p>\n

SYSTEM SUITABILITY<\/h3>\n
The test is not valid unless, in the chromatogram obtained with solution (3), the resolution between the peaks due to the epimers of impurity F is at least 1.2; and the resolution between the peaks due to impurities D and C is at least 1.5.<\/p>\n

MOBILE PHASE<\/h3>\n
Mix 10 volumes of a 6.8% w\/v solution of potassium dihydrogen orthophosphate, adjusted to pH 3.5 with a 50% w\/v solution of dilute orthophosphoric acid, 36 volumes of methanol and 54 volumes of water.<\/p>\n

STORAGE<\/h2>\n
The sealed container should be stored at a temperature not exceeding 30\u00b0.<\/p>\n

LABELLING<\/h2>\n
The label of the sealed container states (1) whether the contents are Benzylpenicillin Potassium or Benzylpenicillin Sodium; (2) the quantity of Benzylpenicillin Potassium or Benzylpenicillin Sodium contained in it in terms of the equivalent amount of benzylpenicillin.<\/p>\n